| Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal … G Masi, S Cupini, L Marcucci, E Cerri, F Loupakis, G Allegrini, IM Brunetti, ... Annals of surgical oncology 13, 58-65, 2006 | 221 | 2006 |
| First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified … G Masi, G Allegrini, S Cupini, L Marcucci, E Cerri, I Brunetti, E Fontana, ... Annals of oncology 15 (12), 1766-1772, 2004 | 152 | 2004 |
| FOLFOXIRI/bevacizumab (bev) versus FOLFIRI/bev as first-line treatment in unresectable metastatic colorectal cancer (mCRC) patients (pts): Results of the phase III TRIBE trial … A Falcone, C Cremolini, G Masi, S Lonardi, V Zagonel, L Salvatore, ... Journal of Clinical Oncology 31 (15_suppl), 3505-3505, 2013 | 119 | 2013 |
| Activity and safety of cetuximab plus modified FOLFOXIRI followed by maintenance with cetuximab or bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer: a … C Cremolini, C Antoniotti, S Lonardi, G Aprile, F Bergamo, G Masi, ... JAMA oncology 4 (4), 529-536, 2018 | 114 | 2018 |
| Neuromuscular junction instability and altered intracellular calcium handling as early determinants of force loss during unloading in humans E Monti, C Reggiani, MV Franchi, L Toniolo, M Sandri, A Armani, ... The Journal of Physiology 599 (12), 3037-3061, 2021 | 72 | 2021 |
| Alterations of extracellular matrix mechanical properties contribute to age-related functional impairment of human skeletal muscles P Pavan, E Monti, M Bondí, C Fan, C Stecco, M Narici, C Reggiani, ... International Journal of Molecular Sciences 21 (11), 3992, 2020 | 68 | 2020 |
| Mechanics of the power stroke in myosin II L Marcucci, L Truskinovsky Physical Review E 81 (5), 051915, 2010 | 42 | 2010 |
| Switching of myosin-V motion between the lever-arm swing and brownian search-and-catch K Fujita, M Iwaki, AH Iwane, L Marcucci, T Yanagida Nature communications 3 (1), 956, 2012 | 39 | 2012 |
| FOLFOXIRI plus bevacizumab (bev) versus FOLFIRI plus bev as first-line treatment of metastatic colorectal cancer (MCRC): Results of the phase III randomized TRIBE trial. F Loupakis, C Cremolini, G Masi, S Lonardi, V Zagonel, P Trenta, ... Journal of Clinical Oncology 31 (4_suppl), 336-336, 2013 | 38 | 2013 |
| From single muscle fiber to whole muscle mechanics: a finite element model of a muscle bundle with fast and slow fibers L Marcucci, C Reggiani, AN Natali, PG Pavan Biomechanics and modeling in mechanobiology 16, 1833-1843, 2017 | 37 | 2017 |
| First-line 5-fluorouracil/folinic acid, oxaliplatin and irinotecan (FOLFOXIRI) does not impair the feasibility and the activity of second line treatments in metastatic … G Masi, L Marcucci, F Loupakis, E Cerri, C Barbara, S Bursi, G Allegrini, ... Annals of oncology 17 (8), 1249-1254, 2006 | 37 | 2006 |
| Fibre and extracellular matrix contributions to passive forces in human skeletal muscles: An experimental based constitutive law for numerical modelling of the passive element … L Marcucci, M Bondì, G Randazzo, C Reggiani, AN Natali, PG Pavan PLoS One 14 (11), e0224232, 2019 | 33 | 2019 |
| Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trial G Masi, C Vivaldi, L Fornaro, S Lonardi, P Buccianti, A Sainato, ... European Journal of Cancer 110, 32-41, 2019 | 32 | 2019 |
| Second-line chemotherapy (CT) with or without bevacizumab (BV) in metastatic colorectal cancer (mCRC) patients (pts) who progressed to a first-line treatment containing BV … G Masi, F Loupakis, L Salvatore, C Cremolini, L Fornaro, M Schirripa, ... Journal of Clinical Oncology 31 (15_suppl), 3615-3615, 2013 | 32 | 2013 |
| A 3D diffusional-compartmental model of the calcium dynamics in cytosol, sarcoplasmic reticulum and mitochondria of murine skeletal muscle fibers L Marcucci, M Canato, F Protasi, GJM Stienen, C Reggiani PLoS One 13 (7), e0201050, 2018 | 29 | 2018 |
| Muscle contraction: A mechanical perspective L Marcucci, L Truskinovsky The European Physical Journal E 32, 411-418, 2010 | 29 | 2010 |
| Increase of resting muscle stiffness, a less considered component of age-related skeletal muscle impairment L Marcucci, C Reggiani European journal of translational myology 30 (2), 2020 | 28 | 2020 |
| From single molecule fluctuations to muscle contraction: a Brownian model of AF Huxley's hypotheses L Marcucci, T Yanagida PLoS One 7 (7), e40042, 2012 | 27 | 2012 |
| Mechanosensing in myosin filament solves a 60 years old conflict in skeletal muscle modeling between high power output and slow rise in tension L Marcucci, C Reggiani Frontiers in Physiology 7, 221591, 2016 | 24 | 2016 |
| Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab G Allegrini, L Coltelli, P Orlandi, A Fontana, A Camerini, A Ferro, ... Pharmacogenomics 15 (16), 1985-1999, 2014 | 24 | 2014 |
